Clovis Oncology (CLVSQ)
OTHER OTC:CLVSQ
Holding CLVSQ?
Track your performance easily

Clovis Oncology (CLVSQ) Financial Statements

0 Followers

Clovis Oncology Financial Overview

Clovis Oncology's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Clovis Oncology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 30.66M$ 32.14M$ 34.25M$ 35.97M$ 37.92M
Gross Profit$ 22.05M$ 22.93M$ 24.83M$ 26.24M$ 28.07M
EBIT$ -46.12M$ -62.26M$ -51.75M$ -56.71M$ -59.23M
EBITDA$ -43.66M$ -60.36M$ -49.82M$ -54.72M$ -57.21M
Net Income Common Stockholders$ -56.01M$ -71.33M$ -60.17M$ -64.39M$ -67.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 58.32M$ 94.58M$ 122.24M$ 143.43M$ 171.95M
Total Assets$ 346.77M$ 392.86M$ 451.53M$ 472.83M$ 508.00M
Total Debt$ 438.32M$ 668.38M$ 653.56M$ 638.37M$ 623.62M
Net Debt$ 380.00M$ 573.80M$ 531.32M$ 494.94M$ 451.67M
Total Liabilities$ 764.66M$ 760.55M$ 754.84M$ 751.67M$ 733.46M
Stockholders Equity$ -417.89M$ -367.69M$ -303.31M$ -278.84M$ -225.46M
Cash Flow-
Free Cash Flow$ -40.70M$ -35.17M$ -58.56M$ -41.41M$ -46.16M
Operating Cash Flow$ -40.61M$ -35.13M$ -58.49M$ -41.34M$ -46.07M
Investing Cash Flow$ -89.00K$ -46.00K$ -62.00K$ -69.00K$ -89.00K
Financing Cash Flow$ 6.18M$ 9.14M$ 37.86M$ 13.17M$ -12.33M
Currency in USD

Clovis Oncology Earnings and Revenue History

Clovis Oncology Debt to Assets

Clovis Oncology Cash Flow

Clovis Oncology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis